| 产品详情 |
| Edit |   |
|---|
| Product Name | Ropivacaine Hydrochloride Monohydrate (S-Ropivacaine HCl) |
|---|
| Description | Purity ≥ 98.5%. Ropivacaine (rINN) is a local anaesthetic drug belonging to the amino amide group. The name ropivacaine refers to both the racemate and the marketed S-enantiomer. Ropivacaine hydrochloride is commonly marketed by AstraZeneca under the trade name Naropin. Ropivacaine was developed after bupivacaine was noted to be associated with cardiac arrest, particularly in pregnant women. Ropivacaine was found to have less cardiotoxicity than bupivacaine in animal models. Identification: 1. Positive reaction 2. IR meets USP34 requirement Absorbance: A405: ≤ 0.03 A436: ≤ 0.025 pH: 4.5-6.0 Optical Isomers: ≤ 0.5% Water: 5.0-6.0% Heavy Metals: ≤ 0.001% Optical Rotation: -215 to -255° 2,6-Dimethylaniline: ≤ 0.001% Related Substances: Bupivacaine: ≤ 0.2% Single Impurities: ≤ 0.1% Total Impurities: ≤ 0.5% Solubility: Methanol, Water Conforms to USP34 |
|---|
| Size | 10g |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 20729 |
|---|
| Price | |
|---|
| Order / More Info | Ropivacaine Hydrochloride Monohydrate (S-Ropivacaine HCl) from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|